FDA-approved peptides like semaglutide or tirzepatide are designed to be used individually under medical supervision
Similar to the NPSI, the baseline total score (out of a maximum of 84) of the SFNSL was in the lower end of the range: 24.8 for the ARA 290 and 21.3 for the placebo group respectively
Location patterns differ significantly: oral and genital areas are most common for viral lesions, while acne predominantly affects the T-zone (forehead, nose, chin) and can appear anywhere with oil glands
There is no clinically validated human dosing protocol
Combination Side Effects Since some of the side effects of these medications overlap, combining them may lead to more severe side effects in some individuals, such as dizziness, drowsiness, and gastrointestinal side effects like constipation, gas, bloating, and nausea